David Bowen

37.7k citations
132 papers · 5.4k · 1 hit paper · h-index 36

Impact in

  • Hematology top 0.1%
    • Acute Myeloid Leukemia Research
    • Chronic Myeloid Leukemia Treatments
    • Hematopoietic Stem Cell Transplantation
  • Genetics top 0.5%
    • Myeloproliferative Neoplasms: Diagnosis and Treatment
    • Hemoglobinopathies and Related Disorders

Papers in

    • Acute Myeloid Leukemia Research 103
    • Multiple Myeloma Research and Treatments 10
    • Chronic Myeloid Leukemia Treatments 9
    • Myeloproliferative Neoplasms: Diagnosis and Treatment 22
    • Hemoglobinopathies and Related Disorders 16

David Bowen

123 papers receiving 5.3k citations

David Bowen's Hit Papers

The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials 2001 · 1.2k citations
1.2k0+8+16Years since publication2505007501000

Peers

David Bowen
Comparison fields: 5 of 120
  • Hematology 4.1k
  • Genetics 1.4k
  • Molecular Biology 1.9k
  • Emergency Medicine 228
  • Public Health, Environmental and Occupational Health 694
Replace Sherry Pierce with:
Sherry Pierce United States
Felicetto Ferrara Italy
Martin Höglund Sweden
Luca Malcovati Italy
Steven D. Gore United States
Amy E. DeZern United States
Maria Teresa Voso Italy
Giovanni Del Poeta Italy
Francesco Buccisano Italy
Giuliana Alimena Italy
David Bowen relative to Sherry Pierce United States Sherry Pierce's profile →
Citations per field
00.5×1.7×
Sherry Pierce · 1×
Citations per year

Countries citing papers authored by David Bowen

Since Specialization
Citations

This map shows the geographic impact of David Bowen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Bowen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Bowen more than expected).

Fields of papers citing papers by David Bowen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Bowen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Bowen. The network helps show where David Bowen may publish in the future.

Co-authors

The 25 scholars most cited alongside David Bowen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David Bowen Line = papers co-authored together David Bowen links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 132 papers — load more, or switch the sort, to bring in the rest.

#Work
1
The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials
Hit paper breakdown →
20011183
2 2015350
3 2002239
4 2003210
5 2005180
6 2009127
7 2012124
8 2015124
9 2009112
10 200399
11 201399
12 201498
13 199197
14 199793
15 201888
16 200988
17 200887
18 199181
19 199580
20 199076

About David Bowen

David Bowen is a scholar working on Hematology, Genetics, Molecular Biology, Public Health, Environmental and Occupational Health and Emergency Medicine, having authored 132 papers that have together received 5.4k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (103 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (22 papers), Acute Lymphoblastic Leukemia research (21 papers), Hemoglobinopathies and Related Disorders (16 papers), Hematological disorders and diagnostics (12 papers), Multiple Myeloma Research and Treatments (10 papers), Retinoids in leukemia and cellular processes (9 papers) and Chronic Myeloid Leukemia Treatments (9 papers). The work is most often cited by research in Hematology (4.1k citations), Genetics (1.4k citations), Molecular Biology (1.9k citations), Emergency Medicine (228 citations) and Public Health, Environmental and Occupational Health (694 citations). David Bowen has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Alan K. Burnett, Marion E. Frew, Stephen E. Langabeer, Panagiotis Kottaridis, David C. Linch, Rosemary E. Gale, Keith Wheatley, Anthony H. Goldstone, G Harrison and Helen M. Walker. Their work appears in journals such as Blood, British Journal of Haematology, Leukemia Research, Leukemia and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact